Company / FCF Margin
Sonoma Pharmaceuticals, Inc. FCF Margin History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-1.2%
FY2026
5-year range
-48.4% / -1.2%
FY2022-FY2026
Trend
+93.7%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -97.0% in FY2017 to -1.2% in FY2026.
Based on SEC 10-K filings.
-1.2% in FY2026 with a 5-year CAGR of +25.6%.
Improved from -48.4% to -1.2% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +33.5pp
- 5-Year Change
- +25.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2026, fcf margin increased 93.7% year-over-year.
- Lowest fcf margin in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | -1.2% | +93.7% |
| FY2025 | -18.9% | +61.0% |
| FY2024 | -48.4% | -39.3% |
| FY2023 | -34.7% | -81.9% |
| FY2022 | -19.1% | +28.7% |
| FY2021 | -26.8% | +57.0% |
| FY2020 | -62.3% | +17.8% |
| FY2019 | -75.8% | -13.6% |
| FY2018 | -66.8% | +31.2% |
| FY2017 | -97.0% | -96.7% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026